HUP0202609A3 - Regioselective synthesis of rapamycin derivatives - Google Patents
Regioselective synthesis of rapamycin derivativesInfo
- Publication number
- HUP0202609A3 HUP0202609A3 HU0202609A HUP0202609A HUP0202609A3 HU P0202609 A3 HUP0202609 A3 HU P0202609A3 HU 0202609 A HU0202609 A HU 0202609A HU P0202609 A HUP0202609 A HU P0202609A HU P0202609 A3 HUP0202609 A3 HU P0202609A3
- Authority
- HU
- Hungary
- Prior art keywords
- rapamycin derivatives
- regioselective synthesis
- regioselective
- synthesis
- rapamycin
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40883099A | 1999-09-29 | 1999-09-29 | |
PCT/US2000/026445 WO2001023395A2 (en) | 1999-09-29 | 2000-09-27 | Regioselective synthesis of rapamycin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202609A2 HUP0202609A2 (hu) | 2002-12-28 |
HUP0202609A3 true HUP0202609A3 (en) | 2004-11-29 |
Family
ID=23617953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202609A HUP0202609A3 (en) | 1999-09-29 | 2000-09-27 | Regioselective synthesis of rapamycin derivatives |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1216251B1 (hu) |
JP (1) | JP4289813B2 (hu) |
KR (1) | KR100754236B1 (hu) |
CN (1) | CN1176925C (hu) |
AR (1) | AR029181A1 (hu) |
AT (1) | ATE233269T1 (hu) |
AU (1) | AU782234B2 (hu) |
BR (1) | BR0014433A (hu) |
CA (1) | CA2385461C (hu) |
CZ (1) | CZ300368B6 (hu) |
DE (1) | DE60001510T2 (hu) |
DK (1) | DK1216251T3 (hu) |
EA (1) | EA004331B1 (hu) |
ES (1) | ES2189768T3 (hu) |
HK (1) | HK1044774B (hu) |
HU (1) | HUP0202609A3 (hu) |
IL (2) | IL148542A0 (hu) |
MX (1) | MXPA02003243A (hu) |
NO (1) | NO20021360L (hu) |
NZ (1) | NZ517644A (hu) |
PL (1) | PL200899B1 (hu) |
TW (1) | TWI256395B (hu) |
WO (1) | WO2001023395A2 (hu) |
ZA (1) | ZA200201918B (hu) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
KR20060090803A (ko) * | 2003-09-03 | 2006-08-16 | 와이어쓰 | 3-하이드록시-2-(하이드록시메틸)-2-메틸프로피온산을 갖는무정형 라파마이신 42-에스테르 및 이를 함유하는약제학적 조성물 |
AR046194A1 (es) | 2003-11-04 | 2005-11-30 | Mayo Foundation | Metodo de tratamiento del linfoma de celulas del manto |
SG152234A1 (en) | 2004-04-14 | 2009-05-29 | Wyeth Corp | Regiospecific synthesis of rapamycin 42-ester derivatives |
JP2007532650A (ja) | 2004-04-14 | 2007-11-15 | ワイス | プロリンcci−779(2,2−ビス(ヒドロキシメチル)プロピオン酸とのプロリン−ラパマイシン42−エステル)ならびに細菌リパーゼを使用するプロリンcci−779およびcci−779の二段階酵素的合成 |
AU2005292647A1 (en) | 2004-08-10 | 2006-04-13 | Wyeth | CCI-779 derivatives and methods of making same |
AU2006210572B2 (en) | 2005-02-03 | 2011-08-04 | The General Hospital Corporation | Method for treating gefitinib resistant cancer |
KR20070107030A (ko) | 2005-02-09 | 2007-11-06 | 와이어쓰 | Cci-779 다형체 및 그의 용도 |
CN103110948A (zh) | 2005-11-04 | 2013-05-22 | 惠氏公司 | mTOR抑制剂、赫赛汀和/或HKI-272的抗肿瘤组合 |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
CA2725598C (en) | 2008-06-17 | 2013-10-08 | Wyeth Llc | Antineoplastic combinations containing hki-272 and vinorelbine |
CN101676291B (zh) | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
JP2013518093A (ja) * | 2010-01-28 | 2013-05-20 | フレゼニウス・カビ・オンコロジー・リミテッド | テムシロリムスの製造のための改善された方法およびその中間体 |
CN102020662B (zh) | 2011-01-07 | 2013-02-13 | 天津市炜杰科技有限公司 | 一种驮瑞塞尔制备方法 |
EP2694520A1 (en) * | 2011-04-01 | 2014-02-12 | Sandoz AG | Regioselective acylation of rapamycin at the c-42 position |
CN103421023B (zh) * | 2013-07-30 | 2015-09-23 | 福建省微生物研究所 | 一种替西罗莫司的合成工艺 |
CN104086564B (zh) * | 2014-07-30 | 2019-02-05 | 江苏奥赛康药业股份有限公司 | 一种高纯度坦罗莫司的制备方法 |
CN106146536B (zh) * | 2015-04-25 | 2019-07-26 | 山东新时代药业有限公司 | 一种依维莫司的制备方法 |
JP6942141B2 (ja) * | 2016-03-14 | 2021-09-29 | ウイスコンシン アラムニ リサーチ ファンデーション | 抗がん効能を高めたオリゴ乳酸複合体及びミセル |
CN107561170B (zh) * | 2016-07-02 | 2021-07-30 | 山东新时代药业有限公司 | 一种坦西莫司中间体的分析检测方法 |
CN108948046B (zh) * | 2017-05-20 | 2020-11-10 | 鲁南制药集团股份有限公司 | 一种替西罗莫司的中间体及其制备方法 |
CN108948045A (zh) * | 2017-05-20 | 2018-12-07 | 鲁南制药集团股份有限公司 | 一种替西罗莫司的制备方法 |
CN109206441B (zh) * | 2017-06-30 | 2022-05-20 | 正大天晴药业集团股份有限公司 | 一种依维莫司的纯化方法 |
CN109776570A (zh) * | 2017-11-14 | 2019-05-21 | 上海医药工业研究院 | 一种依维莫司中间体、其制备方法及其应用 |
LT3813946T (lt) | 2018-06-15 | 2024-07-10 | Janssen Pharmaceutica Nv | Rapamicino analogai ir jų panaudojimas |
CN109369679A (zh) * | 2018-12-24 | 2019-02-22 | 江苏卓和药业有限公司 | 一种雷帕霉素的精制方法 |
CN109851626B (zh) * | 2019-01-08 | 2021-11-02 | 扬子江药业集团四川海蓉药业有限公司 | 一种替西罗莫司的分离纯化方法 |
EP4069223A4 (en) | 2019-12-05 | 2023-12-20 | Janssen Pharmaceutica NV | RAPAMYCIN ANALOGS AND THEIR USES |
CN113372359A (zh) * | 2020-03-10 | 2021-09-10 | 鲁南制药集团股份有限公司 | 一种坦西莫司的制备方法 |
CN114106014B (zh) * | 2020-08-27 | 2024-03-15 | 鲁南制药集团股份有限公司 | 一种依维莫司的制备方法 |
CN115028658A (zh) * | 2022-07-06 | 2022-09-09 | 国药集团川抗制药有限公司 | 雷帕霉素硅醇酯及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5120842A (en) * | 1991-04-01 | 1992-06-09 | American Home Products Corporation | Silyl ethers of rapamycin |
US5387680A (en) * | 1993-08-10 | 1995-02-07 | American Home Products Corporation | C-22 ring stabilized rapamycin derivatives |
US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5563145A (en) * | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
-
2000
- 2000-09-14 TW TW089118799A patent/TWI256395B/zh active
- 2000-09-27 NZ NZ517644A patent/NZ517644A/en unknown
- 2000-09-27 AR ARP000105064A patent/AR029181A1/es unknown
- 2000-09-27 KR KR1020027004033A patent/KR100754236B1/ko not_active IP Right Cessation
- 2000-09-27 PL PL354461A patent/PL200899B1/pl not_active IP Right Cessation
- 2000-09-27 MX MXPA02003243A patent/MXPA02003243A/es active IP Right Grant
- 2000-09-27 CN CNB008163685A patent/CN1176925C/zh not_active Expired - Fee Related
- 2000-09-27 WO PCT/US2000/026445 patent/WO2001023395A2/en active IP Right Grant
- 2000-09-27 DE DE60001510T patent/DE60001510T2/de not_active Expired - Lifetime
- 2000-09-27 DK DK00966904T patent/DK1216251T3/da active
- 2000-09-27 CA CA002385461A patent/CA2385461C/en not_active Expired - Fee Related
- 2000-09-27 JP JP2001526545A patent/JP4289813B2/ja not_active Expired - Fee Related
- 2000-09-27 AT AT00966904T patent/ATE233269T1/de not_active IP Right Cessation
- 2000-09-27 AU AU77182/00A patent/AU782234B2/en not_active Ceased
- 2000-09-27 HU HU0202609A patent/HUP0202609A3/hu unknown
- 2000-09-27 EP EP00966904A patent/EP1216251B1/en not_active Expired - Lifetime
- 2000-09-27 ES ES00966904T patent/ES2189768T3/es not_active Expired - Lifetime
- 2000-09-27 CZ CZ20021136A patent/CZ300368B6/cs not_active IP Right Cessation
- 2000-09-27 IL IL14854200A patent/IL148542A0/xx active IP Right Grant
- 2000-09-27 EA EA200200412A patent/EA004331B1/ru not_active IP Right Cessation
- 2000-09-27 BR BR0014433-9A patent/BR0014433A/pt not_active IP Right Cessation
-
2002
- 2002-03-06 IL IL148542A patent/IL148542A/en not_active IP Right Cessation
- 2002-03-07 ZA ZA200201918A patent/ZA200201918B/en unknown
- 2002-03-19 NO NO20021360A patent/NO20021360L/no not_active Application Discontinuation
- 2002-09-02 HK HK02106469.7A patent/HK1044774B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1044774A1 (en) | Regioselective synthesis of rapamycin derivatives | |
AU7830400A (en) | Synthesis of insulin derivatives | |
PL351261A1 (en) | Derivatives of indigoid bisindoles | |
AU3771100A (en) | Synthesis of epothilones | |
HUP0202477A3 (en) | Use of phthalazine derivatives | |
AU3565999A (en) | Synthesis of azetidine derivatives | |
PL352296A1 (en) | Crystalline derivatives of 1-methylocarbapeneme | |
EG23070A (en) | Novel propargylether derivatives | |
HUP0105011A3 (en) | Synthesis method of nitroxymethylphenyl esters of aspirin derivatives | |
PL355811A1 (en) | Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h | |
IL149534A0 (en) | Preparation of 3-substituted-4-arylquinolin-2-one derivatives | |
HUP0204217A3 (en) | Novel a-500359 derivatives | |
PL352409A1 (en) | Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane | |
GB9909756D0 (en) | Synthesis of polycarbonates | |
SI1216251T1 (en) | Regioselective synthesis of rapamycin derivatives | |
AU3739300A (en) | Synthesis of vapol ligands | |
GB0011407D0 (en) | Synthesis of substituted prolines | |
HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
PL331785A1 (en) | Method of obtaining starch derivatives | |
GB9828176D0 (en) | Synthesis of epibatidine derivatives | |
AU4015900A (en) | Synthesis of epoxy-thf compounds | |
PL340157A1 (en) | Method of obtaining derivatives of 2-phenyl-3-aminopyridine | |
TW392769U (en) | Hinge capable of positioning | |
TW392768U (en) | Hinge capable of positioning | |
IL132329A0 (en) | Inhibition of dyslexia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |